Literature DB >> 2386196

Acridine orange flow cytometric analysis of renal cell carcinoma. Clinicopathologic implications of RNA content.

A K el-Naggar1, J G Batsakis, K Teague, G Giacco, V F Guinee, D Swanson.   

Abstract

To explore the potential role that ribonucleic acid (RNA) content analysis may have in the assessment of primary renal cell carcinomas (RCC), biparametric flow cytometric (acridine orange) measurements for DNA/RNA were obtained on 108 fresh neoplastic specimens. RNA content was divided into low and high groups, based on the average RNA content in normal kidney controls. High RNA content was significantly correlated with aneuploidy, high proliferative index, high nuclear grade, cytoplasmic granularity, and large tumor size. No correlation was found between RNA content and patients' sex, race, and clinical stage of the carcinomas. When diploid RCCs were separately analyzed, high RNA content was correlated with high nuclear grade, large tumor size, high clinical stage, and cytoplasmic granularity. There was no correlation between RNA content and the patient's sex or race or the neoplasm's proliferative index. Of the 16 patients that relapsed (5 diploid and 11 aneuploid), four of the diploid and all 11 aneuploid neoplasms displayed high RNA content. The authors' data show that RNA may be a valuable objective and quantitative parameter in the clinicopathologic assessment of RCC.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2386196      PMCID: PMC1877625     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  39 in total

Review 1.  Flow cytometry in clinical cancer research.

Authors:  B Barlogie; M N Raber; J Schumann; T S Johnson; B Drewinko; D E Swartzendruber; W Göhde; M Andreeff; E J Freireich
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

2.  Comparison of cytologic and acridine-orange flow-cytometric detection of malignant cells in human body cavity fluids.

Authors:  R L Katz; T S Johnson; K D Williamson
Journal:  Anal Quant Cytol Histol       Date:  1985-09       Impact factor: 0.302

3.  Well differentiated clear cell renal carcinoma: significance of nuclear deoxyribonucleic acid patterns studied by flow cytometry.

Authors:  L M Rainwater; Y Hosaka; G M Farrow; M M Lieber
Journal:  J Urol       Date:  1987-01       Impact factor: 7.450

4.  DNA content in renal cell carcinoma with reference to tumor heterogeneity.

Authors:  B Ljungberg; R Stenling; G Roos
Journal:  Cancer       Date:  1985-08-01       Impact factor: 6.860

5.  Flow-cytophotometric studies in renal carcinoma.

Authors:  H W Schwabe; H D Adolphs; J Vogel
Journal:  Urol Res       Date:  1983

6.  Malignancy index based on flow cytometry and histology for renal cell carcinomas and its correlation to prognosis.

Authors:  H Baisch; U Otto; G Klöppel
Journal:  Cytometry       Date:  1986-03

7.  Prognostic significance of the DNA content in renal cell carcinoma.

Authors:  B Ljungberg; G Forsslund; R Stenling; A Zetterberg
Journal:  J Urol       Date:  1986-02       Impact factor: 7.450

8.  Prognostic factors in renal carcinoma. An evaluation of operative findings.

Authors:  M J Nurmi
Journal:  Br J Urol       Date:  1984-06

9.  Flow cytometric deoxyribonucleic acid analysis of primary and metastatic human renal cell carcinoma.

Authors:  J L Chin; J E Pontes; O S Frankfurt
Journal:  J Urol       Date:  1985-04       Impact factor: 7.450

10.  DNA content and prognosis in renal cell carcinoma. A comparison between primary tumors and metastases.

Authors:  B Ljungberg; R Stenling; G Roos
Journal:  Cancer       Date:  1986-06-15       Impact factor: 6.860

View more
  2 in total

1.  Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma.

Authors:  J W Slaton; K Inoue; P Perrotte; A K El-Naggar; D A Swanson; I J Fidler; C P Dinney
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

2.  New applications of the acridine orange fluorescence staining method: Screening for circulating tumor cells.

Authors:  Min Liu; Ruizhe Li; Yang Tang; Jiwu Chang; Rong Han; Shumin Zhang; Ning Jiang; Fuling Ma
Journal:  Oncol Lett       Date:  2017-02-13       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.